Furthermore, PRL-expanded Treg (CD4+ Foxp3+) population and improved the efficacy of short-term low-dose anti-CD3 treatment (which induce a transient CD4+ and CD8+ T cell depletion) at achieving diabetes remission in the NOD mice (232). The gene discussed is CD4; the disease is diabetes mellitus.